NCT03506997
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03506997 |
| Title | Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (PERSEUS1) |
| Acronym | PERSEUS1 |
| Recruitment | Unknown status |
| Gender | male |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Institute of Cancer Research, United Kingdom |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | GBR |
CKB BOOST